Four Coronavirus Vaccines Are Undergoing Pre-Clinical Trials In Japan
Japanese companies are currently conducting pre-clinical trials of four vaccines for the new coronavirus, according to the representative of the office of the World Health Organization (WHO) in the Western Pacific region, Dr. Socorro Escalante during a press conference in the online format.
"To date, only one vaccine in Japan is in the second stage of clinical tests. At the same time, four more vaccines are undergoing pre-clinical studies," she said, answering a question about the situation with the creation of a vaccine in Japan.
Speaking about the future production of vaccines in the Western Pacific region, Escalante noted that several countries, including Australia, China, Singapore, and Japan, have expressed their desire to help other countries in this part of the world if they do not have enough production capacity.
Clinical trials of a vaccine developed by the Japanese pharmaceutical company AnGes Inc. began in late June. AnGes Inc. created a DNA vaccine based on nucleic acids. Its tests on rats were successful, and in late May, the company reported that the rodents had developed antibodies. Currently, according to WHO, 26 vaccines, including the Russian one, are undergoing clinical trials around the world.
Japan previously reached an agreement on the supply of vaccines with the British-Swedish pharmaceutical company AstraZeneca and the American Pfizer.
Since the beginning of the pandemic, more than 21.6 million people have been infected with the coronavirus in the world, and more than 775 thousand have died.